Hls Therapeutics (TSE:HLS) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
HLS Therapeutics Inc., a pharmaceutical company specializing in psychiatric and cardiovascular treatments, will be featured at the Bloom Burton & Co. Healthcare Investor Conference. CEO Craig Millian is scheduled to present on April 17, 2024, with the event being webcasted online. Additionally, personal meetings with investors will be conducted by Millian and Interim CFO John Hanna during the conference.
For further insights into TSE:HLS stock, check out TipRanks’ Stock Analysis page.